dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Generic: dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Labeler: camber pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Generic Name
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Labeler
camber pharmaceuticals, inc.
Dosage Form
TABLET
Routes
Active Ingredients
amphetamine aspartate monohydrate 1.25 mg/1, amphetamine sulfate 1.25 mg/1, dextroamphetamine saccharate 1.25 mg/1, dextroamphetamine sulfate 1.25 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
31722-155
Product ID
31722-155_eac552ea-6080-4935-a154-39ab177ef350
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA213709
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2021-05-10
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
31722155
Hyphenated Format
31722-155
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate (source: ndc)
Generic Name
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate (source: ndc)
Application Number
ANDA213709 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1.25 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (31722-155-01)
Packages (1)
Ingredients (4)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "eac552ea-6080-4935-a154-39ab177ef350", "openfda": {"upc": ["0331722158015", "0331722155014", "0331722156011", "0331722159012", "0331722157018", "0331722164016", "0331722163019"], "unii": ["O1ZPV620O4", "6DPV8NK46S", "G83415V073", "JJ768O327N"], "rxcui": ["541363", "541878", "541892", "577957", "577961", "687043", "1009145"], "spl_set_id": ["430cccec-1679-4225-8c86-92d746153b38"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (31722-155-01)", "package_ndc": "31722-155-01", "marketing_start_date": "20210510"}], "brand_name": "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE", "product_id": "31722-155_eac552ea-6080-4935-a154-39ab177ef350", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "31722-155", "dea_schedule": "CII", "generic_name": "dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE MONOHYDRATE", "strength": "1.25 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "1.25 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "1.25 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "1.25 mg/1"}], "application_number": "ANDA213709", "marketing_category": "ANDA", "marketing_start_date": "20210510", "listing_expiration_date": "20261231"}